Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1983 Aug;41(2):816–821. doi: 10.1128/iai.41.2.816-821.1983

Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.

S M Feinstone, K B Mihalik, T Kamimura, H J Alter, W T London, R H Purcell
PMCID: PMC264712  PMID: 6409813

Abstract

To determine whether a non-A, non-B hepatitis agent contained essential lipids, we extracted with chloroform a dilution of human plasma that contained approximately 10(4) chimpanzee infectious doses of non-A, non-B hepatitis virus and then tested for infectivity in chimpanzees. In addition, we treated a serum containing hepatitis B virus in the same way. Both of these samples were also sham extracted as controls. Known chloroform-sensitive and chloroform-resistant viruses were added directly to the hepatitis-containing serum or plasma as internal controls or to fetal calf serum as external controls and were assayed for infectivity in vitro after chloroform extraction or sham extraction. All infectivity of the diluted plasma that contained at least 10(4) chimpanzee infective doses of non-A, non-B hepatitis agent and all infectivity of the serum that contained 10(3.5) chimpanzee infective doses of hepatitis B virus were destroyed by chloroform. The chloroform-sensitive control viruses were completely inactivated, but the chloroform-resistant control viruses lost less than 0.5 log10 of infectivity. Sham-extracted non-A, non-B hepatitis agent-containing plasma was shown to maintain its infectivity in chimpanzees that had initially been inoculated with the chloroform-extracted plasma. Thus, both hepatitis type B and non-A, non-B hepatitis appear to be caused by viruses that can be inactivated by a lipid solvent.

Full text

PDF
816

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Purcell R. H., Holland P. V., Popper H. Transmissible agent in non-A, non-B hepatitis. Lancet. 1978 Mar 4;1(8062):459–463. doi: 10.1016/s0140-6736(78)90131-9. [DOI] [PubMed] [Google Scholar]
  2. Barker L. F., Maynard J. E., Purcell R. H., Hoofnagle J. H., Berquist K. R., London W. T., Gerety R. J., Krushak D. H. Hepatitis B virus infection in chimpanzees: titration of subtypes. J Infect Dis. 1975 Oct;132(4):451–458. doi: 10.1093/infdis/132.4.451. [DOI] [PubMed] [Google Scholar]
  3. Dienstag J. L., Krotoski W. A., Howard W. A., Purcell R. H., Neva F. A., Galambos J. T., Glew R. H. Non-A, non-B hepatitis after experimental transmission of malaria by inoculation of blood. J Infect Dis. 1981 Feb;143(2):200–209. doi: 10.1093/infdis/143.2.200. [DOI] [PubMed] [Google Scholar]
  4. Feinstone S. M., Alter H. J., Dienes H. P., Shimizu Y., Popper H., Blackmore D., Sly D., London W. T., Purcell R. H. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis. 1981 Dec;144(6):588–598. doi: 10.1093/infdis/144.6.588. [DOI] [PubMed] [Google Scholar]
  5. Feinstone S. M., Kapikian A. Z., Purcell R. H., Alter H. J., Holland P. V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975 Apr 10;292(15):767–770. doi: 10.1056/NEJM197504102921502. [DOI] [PubMed] [Google Scholar]
  6. Gerin J. L., Purcell R. H., Hoggan M. D., Holland P. V., Chanock R. M. Biophysical properties of Australia antigen. J Virol. 1969 Nov;4(5):763–768. doi: 10.1128/jvi.4.5.763-768.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hollinger F. B., Gitnick G. L., Aach R. D., Szmuness W., Mosley J. W., Stevens C. E., Peters R. L., Weiner J. M., Werch J. B., Lander J. J. Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology. 1978;10(1):60–68. doi: 10.1159/000148969. [DOI] [PubMed] [Google Scholar]
  8. Hoofnagle J. H., Gerety R. J., Tabor E., Feinstone S. M., Barker L. F., Purcell R. H. Transmission of non-A, non-B hepatitis. Ann Intern Med. 1977 Jul;87(1):14–20. doi: 10.7326/0003-4819-87-1-14. [DOI] [PubMed] [Google Scholar]
  9. Prince A. M., Brotman B., Grady G. F., Kuhns W. J., Hazzi C., Levine R. W., Millian S. J. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1974 Aug 3;2(7875):241–246. doi: 10.1016/s0140-6736(74)91412-3. [DOI] [PubMed] [Google Scholar]
  10. Shimizu Y. K., Feinstone S. M., Purcell R. H., Alter H. J., London W. T. Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science. 1979 Jul 13;205(4402):197–200. doi: 10.1126/science.451589. [DOI] [PubMed] [Google Scholar]
  11. Tabor E., Gerety R. J. Inactivation of an agent of human non-A, non-B hepatitis by formalin. J Infect Dis. 1980 Nov;142(5):767–770. doi: 10.1093/infdis/142.5.767. [DOI] [PubMed] [Google Scholar]
  12. Yoshizawa H., Itoh Y., Iwakiri S., Kitajima K., Tanaka A., Tachibana T., Nakamura T., Miyakawa Y., Mayumi M. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterology. 1982 Mar;82(3):502–506. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES